Article Text

PDF
Are the loading dose treatment groups superior to the 150 mg without loading dose group in the secukinumab FUTURE 5 study?
  1. Bernardo Matos da Cunha
  1. Internal Medicine, Rheumatology Team, Sarah Network of Rehabilitation Hospitals, Brasília, DF, Brazil
  1. Correspondence to Dr Bernardo Matos da Cunha, Sarah Network of Rehabilitation Hospitals, Brasília-DF.; bmcunha{at}sarah.br

Statistics from Altmetric.com

I read with great interest the article by Mease et al1 because equivalence in efficacy with lesser secukinumab total doses could be less expensive to payers and more safe and comfortable to patients. However, I am somewhat disappointed with the reported results.

The …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.